Sanofi inaugurates its Shanghai foreign-invested R&D Innovation Center and signs partnership with the Excellence Translational Center

Sanofi (SNY.US) inaugurated its Shanghai Foreign Investment R&D Innovation Center and signed a cooperation agreement for the Sanofi-Fudan University Huashan Hospital "Excellence in Transformation Center". In 2025, Sanofi's revenue will reach 46.7 billion euros, with China being Sanofi's second largest market globally. According to the plan, the center will become Sanofi's largest translational medicine research center in China, gathering global R&D resources to advance innovative drug development in key areas such as immunology, chronic diseases, oncology, and rare diseases. (Yicai Global).